Sino Biopharmaceutical Limited
HKSE:1177.HK
Sector
Location
Market Cap
USD 16.89 B
Share Price
USD 0.94
Avg Daily Volume
180,194,256
Change (1 day)
-0.34%
Change (1 year)
125.60%
Change (YTD)
129.25%
Sino Biopharmaceutical Limited Operating Cash Flow for the year ending December 31, 2024: USD 906.01 M
Sino Biopharmaceutical Limited Operating Cash Flow is USD 906.01 M for the year ending December 31, 2024, a 6.05% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sino Biopharmaceutical Limited Operating Cash Flow for the year ending December 31, 2023 was USD 854.36 M, a -5.90% change year over year.
-
Sino Biopharmaceutical Limited Operating Cash Flow for the year ending December 31, 2022 was USD 907.88 M, a 7.50% change year over year.
-
Sino Biopharmaceutical Limited Operating Cash Flow for the year ending December 31, 2021 was USD 844.55 M, a 3.52% change year over year.
-
Sino Biopharmaceutical Limited Operating Cash Flow for the year ending December 31, 2020 was USD 815.84 M, a 6.70% change year over year.
StockViz
Competitors
Fresenius SE & Co. KGaA
USD 54.32
FRE.DE
-0.03
-0.06%
Labcorp Holdings Inc.
USD 275.77
LH
+5.28
1.95%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.90
603392.SS
+0.11
1.47%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.35
300832.SZ
+0.11
1.36%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.38
0874.HK
-0.02
-0.76%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.91
600079.SS
-0.03
-1.15%
AddLife AB (publ)
USD 17.71
ALIF-B.ST
+0.48
2.79%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
-0.08
-1.83%
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Fresenius SE & Co. KGaA
USD 54.32
FRE.DE
-0.03
-0.06%
Labcorp Holdings Inc.
USD 275.77
LH
+5.28
1.95%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.90
603392.SS
+0.11
1.47%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.35
300832.SZ
+0.11
1.36%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.38
0874.HK
-0.02
-0.76%
Humanwell Healthcare (Group) Co.,Ltd.
USD 2.91
600079.SS
-0.03
-1.15%
AddLife AB (publ)
USD 17.71
ALIF-B.ST
+0.48
2.79%
Guangzhou Kingmed Diagnostics Group Co., Ltd.
USD 4.20
603882.SS
-0.08
-1.83%
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%